If you've just been injured, or you love someone who has, this is the question that matters most. You'll find two kinds of bad answers online: breathless "paralysis cured!" headlines, and bleak "nothing will ever change" cynicism. Neither is accurate.

Here is the honest version, current as of July 2026, with sources you can check.

🧭
The short answer: No therapy yet reverses a chronic spinal cord injury — nothing on the market or in trials regrows the cord back to normal. But the last two years produced something real: the first FDA-authorized device that restores hand function after chronic SCI, the first human stem-cell results showing measurable movement gains, and brain-and-spine technology that let paralyzed people walk and control computers by thought. The accurate story isn't "a cure is here" or "nothing works." It's steady, multi-front progress that restores function — not a single cure around the corner.

Why This Question Is So Hard to Answer

SCI research moves on several separate tracks at once — stimulation, brain implants, cell transplants, drugs, and regeneration biology — and they're at wildly different stages. Some are FDA-authorized and in clinics today; some are dazzling results in a single person; some are still only in mice; and several heavily promoted drugs have outright failed their big trials. Lumping them together as "the cure" is exactly how hope gets exploited. So this article sorts every approach by how far along it actually is.

First: What "Cure" Even Means

Researchers and the major foundations have largely stopped using "cure" to mean "regrow the cord to exactly how it was." That isn't close, and no credible scientist claims it is. Instead, the working goal is restoring meaningful function — and which function often matters more to people living with SCI than walking does: hand and arm use, bladder and bowel control, stable blood pressure, sexual function, less spasticity and pain. Several of those are advancing faster than "walking again." Keep that reframing in mind every time you read the word "cure."

What's Actually Available Now

Only a short list of things in this entire article are FDA-authorized and usable today. Everything else is a research study.

ARC-EX (ONWARD Medical) — the genuine 2024 milestone. In December 2024 the FDA granted De Novo authorization to the ARC-EX System — the first non-invasive spinal cord stimulation device cleared for chronic SCI. Electrodes on the skin over the back of the neck deliver stimulation paired with rehab to improve hand strength and sensation in people with chronic, incomplete tetraplegia. In the pivotal Up-LIFT trial of 65 participants (published in Nature Medicine), about 90% improved in strength or function and most reported better quality of life. In November 2025 the FDA expanded the clearance to home use. Two honest caveats: this is a De Novo authorization, not a full PMA "approval," and it improves function — it does not repair the cord.

ExaStim (ANEUVO) — a second non-invasive device, cleared in 2026. In April 2026 the FDA cleared ANEUVO's ExaStim, a portable transcutaneous (skin-surface, non-implanted) spinal cord stimulation system. Like ARC-EX, it is indicated to improve hand sensation and strength in adults (18–75) with chronic, incomplete SCI when paired with functional task practice, and it is cleared for both clinic and home use (it had carried a European CE Mark since April 2025). It gives people a second FDA-cleared non-invasive option — but, like ARC-EX, it restores function and does not repair the cord.

Functional electrical stimulation (FES). The decades-old, widely available workhorse of rehab: electrical current applied to muscles or nerves to produce useful movement — grasp, FES cycling, standing, cough and bladder assist. A 2025 review of 23 randomized trials found FES meaningfully improves respiratory function. It's increasingly combined with the newer spinal-stimulation and brain-implant approaches below.

✅
The practical takeaway: if a clinic offers you anything other than these as an available "treatment" — especially if you have to pay for it — you're looking at research (at best) or a scam (at worst). Skip to the stem-cell section for why that matters.

Spinal Stimulation and the Brain–Spine "Digital Bridge"

This is the fastest-moving and most credible area — not because it heals the cord, but because it reactivates circuits that survive below the injury.

Epidural stimulation (research programs). Implanted electrodes on the surface of the cord, paired with intensive training, have let people with chronic SCI in programs at the University of Louisville (Harkema/Angeli) and Mayo Clinic recover voluntary movement, and stand or step with assistance. A 2024 systematic review found that across pooled participants, many achieved assisted standing or stepping and improved walking — encouraging and directionally reproducible, but built on small cohorts with varied protocols. These remain research-only (no FDA approval for this use).

Restoring autonomic function — the underrated story. The same stimulation is being aimed at problems that affect daily life more than walking. ONWARD's implanted ARC-IM system targets the dangerous blood-pressure instability many people face after SCI; in September 2025, papers in Nature and Nature Medicine reported it produced immediate, durable blood-pressure stabilization in early participants, and in August 2025 the FDA approved the IDE for its Empower BP pivotal trial, which enrolled its first participant in February 2026 (at Craig Hospital in Denver) and is now recruiting across roughly 20 sites in the US, Canada, and Europe. Epidural-stimulation groups have similarly reported gains in bladder, bowel, and temperature regulation. ARC-IM is still investigational.

The brain–spine "digital bridge." In 2023, the NeuroRestore team (Courtine and Bloch) published in Nature a wireless system linking brain implants that decode intention to move to electrodes stimulating the spinal cord — a "digital bridge" that let a paralyzed man, Gert-Jan Oskam, stand, walk, and climb stairs under his own volition, reliably for over a year. It's a landmark. It's also, as of mid-2026, still a single-participant proof of concept being carried toward broader trials — not a product.

Brain–Computer Interfaces

BCIs read signals directly from the brain to control a cursor, a device, a robotic arm, or synthesized speech. For high-level injuries they can restore communication and digital independence — but it's worth being clear-eyed: a BCI routes around the injured cord; it doesn't repair it, and every system below is investigational.

Stem Cells and Cell Therapy

This is the track most people mean by "cure" — replacing or supporting lost cells in the cord — and it's also the most contaminated by hype and outright fraud. Here's where the legitimate science actually stands. The honest summary: real but small, mostly early-phase, and mostly demonstrating safety rather than proven recovery.

⚠️
This is the most important paragraph here. Legitimate cell-therapy trials are run under regulatory oversight and are free to participants. Offshore clinics charging $20,000–$100,000+ for "stem cell treatments" have no evidence of benefit for SCI and have caused real harm — infection, tumors, neurological worsening, death. If you're paying for it, it isn't the research described above. See Stem Cells & Peptides for SCI and Avoiding Scams After SCI.

Drugs to Protect or Regrow the Cord — Including the Disappointments

Accuracy means reporting failures, not just press releases. The drug track has been humbling:

The Breakthroughs That Are Real — But Still in Animals

The most spectacular "regrew the cord, restored walking" headlines are true — in mice. They matter because they teach us how repair could work, but the leap from rodent to human in SCI has failed far more often than it has succeeded, so read these as foundations, not imminent treatments.

So — Is a Cure Close?

Holding all of it honestly:

What this means for you practically: the legitimate way to access tomorrow's therapies is through registered clinical trials, which are free to join. You can search recruiting SCI studies in our Clinical Trials Finder (updated daily from ClinicalTrials.gov data), and learn how to evaluate any specific approach in Clinical Trials & SCI Research, Honestly. For the stimulation devices specifically, see Spinal Cord Stimulators.

Sources & Further Reading

Research current to July 2026. This field moves fast — verify the latest at pubmed.gov and in our daily-updated Clinical Trials Finder.

Stimulation & brain–spine interface

Brain–computer interfaces

Cell therapy, drugs & regeneration

SCI.help articles are information, not medical advice. Research status changes quickly; confirm anything you're considering with your care team and verify a trial's standing before enrolling. Legitimate trials never charge you to participate.

Related reading

Research
Stem Cells & Peptides: What the Research Shows
Research
Spinal Cord Stimulators
Medical
Clinical Trials & SCI Research, Honestly
Medical
Will I Recover? Prognosis & Realistic Hope
Medical
Avoiding Scams After SCI
Tool
Clinical Trials Finder

Heard about a treatment and want to evaluate it?

Ask the community, or share what you've found. Honest, sourced information is how we protect each other from hype.

Research & Trials Forum →
Based on published research, FDA actions, and company disclosures as of July 2026. The field moves fast — verify recent developments at pubmed.gov and in our Clinical Trials Finder (updated daily). · Last reviewed July 2026